Ketamine for Chronic Pain and Mental Health: Regulations, Legalities, and the Growth of Infusion Clinics.
Andrew BloomfieldNorine ChanLeah FrymlReuben HoraceSrinivas PyatiPublished in: Current pain and headache reports (2023)
In the management of chronic pain, ketamine has shown potential to manage neuropathic pain and complex regional pain syndrome and has been used as a treatment for chronic pain management by clinics across the USA. Analogous to the historic rise of lidocaine clinics, ketamine clinics are demonstrating a similar pattern of unregulated growth. Ketamine is an anesthetic and analgesic agent commonly used in the perioperative setting and emergency department for sedation and pain management (Mo et al in West J Emerg Med 21(2):272-281, 2020). It was approved for use by the Federal Drug Administration in the USA in the 1970s as the sole anesthetic agent for short diagnostic and surgical procedures (Coppel et al. in Anaesthesia 28(3):293-296, 1973; Schwenk et al. in Reg Anesth Pain Med 43(5):456-466, 2018). Regarding its rising popularity as a treatment option in mental health, ketamine holds promise as a rapidly acting treatment for suicidal ideation and refractory depression.
Keyphrases
- pain management
- chronic pain
- neuropathic pain
- mental health
- primary care
- emergency department
- spinal cord injury
- spinal cord
- drug administration
- depressive symptoms
- machine learning
- patients undergoing
- acute kidney injury
- big data
- sleep quality
- smoking cessation
- deep learning
- artificial intelligence
- combination therapy
- drug induced